- Home
- Member Resources
- Articles
-
The CAP proudly announces that 2024 marks 75 successful years in Proficiency Testing (PT) and External Quality Assessment (EQA), defined by resilience, innovation, and an unwavering commitment to transforming patients' lives. We celebrate the laboratory professionals, the unsung heroes, who have played an instrumental role in shaping CAP’s PT/EQA programs and revolutionizing patient care.
-
In this series, Karim Sirgi, MD, FCAP, details the causes, impacts, and solutions to workload distribution challenges.
-
In this series, Karim Sirgi, MD, FCAP details the causes, impacts, and solutions to workload distribution challenges.
-
In this series, Karim Sirgi, MD, FCAP details the causes, impacts, and solutions to workload distribution challenges.
-
The CAP spoke to Dr. Megha Joshi for Asian American and Pacific Islander Heritage Month to hear her story and get her thoughts on how the CAP can help the next generation of AAPI pathologists.
-
This article examines the clinical importance of HRD status for patients with ovarian, breast, pancreas, and prostate cancers, as well as methodologies for measurement.
-
Dr. Karim Sirgi shares that from his years of leading a large medical group and medical staff organization he has learned that internal tensions most often, if not always, revolve around matters related to group relational and logistical dynamic, not regulatory issues.
-
This Jewish American Heritage Month we recognize the impact of pathologist Ruth L. Kirschstein on the field of medicine, particularly in biomedical research and public health.
-
A history of targeted therapy in breast cancer and focus more specifically on the sequential development ADC therapy in mBCA as established in the underlying clinical trials studies.
-
The CAP recently published an evidence-based guideline for the testing of immunotherapy biomarkers, including PD-L1 and TMB, in patients with non-small cell lung carcinoma.
-
Pathologist-led See, Test & Treat programs help bridge gaps in care for minority communities, such as the Arlington, Texas, event, which serves a Vietnamese population.
-
Dr. Ronald Paler Jr. provides a history of targeted therapy in breast cancer, focusing specifically on the sequential development of ADC therapy in mBCA as established in the underlying clinical trials studies.
-
The CAP spoke to Dr. Rouba Ali-Fehmi for Arab American Heritage Month to hear her story and get her thoughts on how the CAP can help the next generation of Arab American pathologists.
-
Written by inspection team leaders, this guide helps laboratory directors and their staff prepare for a CAP inspection.
-
While the risk of malignancy and prognosis based on tumor subtype are variable, targeted therapy can be helpful in both the metastatic setting and in patients for whom surgical resection would cause significant morbidity.
-
During Welcome to Pathology: Celebration and Q&A for Newly Matched Pathology Residents, expert pathologists shared ways to be the best Resident in a pathology program
-
Recently elected CAP President, Donald Karcher, MD, FCAP, shares his advocacy priorities for the College of American Pathologists.